FMR LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 76 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
FMR LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$4,185,716
-54.0%
2,847,426
-0.6%
0.00%
-100.0%
Q2 2023$9,108,945
-34.1%
2,864,448
-51.1%
0.00%0.0%
Q1 2023$13,830,566
+34.1%
5,860,410
+97.2%
0.00%0.0%
Q4 2022$10,310,658
-57.3%
2,971,371
-9.8%
0.00%
-66.7%
Q3 2022$24,150,000
+32.2%
3,294,629
+17.6%
0.00%
+50.0%
Q2 2022$18,266,000
+45.7%
2,801,531
+12.9%
0.00%
+100.0%
Q1 2022$12,536,000
+52.5%
2,482,323
+133.6%
0.00%0.0%
Q4 2021$8,223,000
+46.5%
1,062,453
+180.1%
0.00%
Q3 2021$5,614,000
+39.8%
379,300
+53.4%
0.00%
Q2 2021$4,015,000247,2000.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$131,458,00059.13%
Apoletto Ltd 15,093,969$98,413,00027.22%
Foresite Capital Management IV, LLC 13,282,181$86,600,00023.32%
MIC Capital Management UK LLP 3,060,569$19,955,0003.90%
Alphabet Inc. 5,865,125$38,241,0002.08%
HSG Holding Ltd 3,045,997$19,860,0001.83%
Board of Trustees of The Leland Stanford Junior University 1,647,882$10,744,0000.72%
SG3 Management, LLC 600,000$3,912,0000.46%
KETTLE HILL CAPITAL MANAGEMENT, LLC 157,700$1,028,0000.26%
Artal Group S.A. 700,000$4,564,0000.24%
View complete list of LYELL IMMUNOPHARMA INC shareholders